View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Comment
November 30, 2021updated 11 Jul 2022 2:16pm

Use of virtual trials and CROs helps trial completion rate of rescue clinical trials

Recent data show the use of virtual components together with CROs increases the chances of success for rescue clinical trials.

By GlobalData Healthcare

Rescue clinical trials, which can have a delayed estimated start date or delayed estimated end date, often require outside sourcing, such as to contract research organisations (CROs), to successfully complete. GlobalData’s Pharma Intelligence Centre has compiled data on rescue trials, showing a trend in the completion rate.

Free Case Study
img

Direct-to-Patient Trials: How IRT Plays an Important Role in Bellerophon's Direct-to-Patient Trials

As the industry strengthens its focus on patient centricity, Direct-to-Patient clinical trials have emerged as a popular trial design that have the potential to increase patient recruitment and retention. IRT plays a crucial role in the success of a Direct-to-Patient trial. Because drug supplies are being managed and shipped from distribution facilities directly to patients’ homes, a sponsor must have a high-quality system in place to accurately track the chain of custody, ensure patient-blinding and handle other logistical challenges. What You Will Learn Benefits and challenges associated with the Direct-to-Patient model Bellerophon's top considerations when implementing this trial design How IRT can equip study teams to successfully track chain of custody, ensure patient blinding, and handle logistical challenges
by Suvoda
Enter your details here to receive your free Case Study.

Since the Covid-19 pandemic began, sponsors have turned to the use of virtual trials components to successfully initiate and complete trials. When looking at the completion rate of rescue trials since 2010, those with virtual components had a higher completion rate by 3.2%. Rescue trials that used both virtual components and a CRO did even better, with an 84.5% completion rate compared with trials that had neither virtual components nor CROs (78.8%), as seen in Figure 1. These data points indicate that the usage of not only virtual components, but also CROs, increases the chances of successfully completing a rescue clinical trial.

Related Companies

Free Case Study
img

Direct-to-Patient Trials: How IRT Plays an Important Role in Bellerophon's Direct-to-Patient Trials

As the industry strengthens its focus on patient centricity, Direct-to-Patient clinical trials have emerged as a popular trial design that have the potential to increase patient recruitment and retention. IRT plays a crucial role in the success of a Direct-to-Patient trial. Because drug supplies are being managed and shipped from distribution facilities directly to patients’ homes, a sponsor must have a high-quality system in place to accurately track the chain of custody, ensure patient-blinding and handle other logistical challenges. What You Will Learn Benefits and challenges associated with the Direct-to-Patient model Bellerophon's top considerations when implementing this trial design How IRT can equip study teams to successfully track chain of custody, ensure patient blinding, and handle logistical challenges
by Suvoda
Enter your details here to receive your free Case Study.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena